HomeEntertainmentSamsung Biologics falls 3% after $1.8 billion PolyPeptide acquisition Samsung Biologics falls 3% after $1.8 billion PolyPeptide acquisition July 20, 2026byadmin Samsung Biologics falls 3% after $1.8 billion PolyPeptide acquisition Source link
Argentina and China renew currency swap deal for five years Argentina and China renew currency swap deal for five years Source link
MapLight Therapeutics CEO Christopher Kroeger sells $3.2m in stock MapLight Therapeutics CEO Christopher Kroeger sells $3.2m in stock Source link
Old Republic SVP Carolyn Monroe sells $516k in company stock Old Republic SVP Carolyn Monroe sells $516k in company stock Source link